Literature DB >> 11469455

Chronic comorbidity in patients with early rheumatoid arthritis: a descriptive study.

E J Kroot1, A M van Gestel, H L Swinkels, M M Albers, L B van de Putte, P L van Riel.   

Abstract

OBJECTIVE: To study the presence of chronic coexisting diseases in patients with rheumatoid arthritis (RA) and its effect on RA treatment, disease course, and outcome during the first years of the disease.
METHODS: From January 1985 to December 1990, 186 patients with recent onset RA were enrolled in a prospective longitudinal study. Between January 1991 and November 1992 patients were interviewed on the basis of a comorbidity questionnaire. For analysis the diseases were coded according to the International Classification of Diseases, 9th revision, Clinical Modification (ICD-9-CM) medical diagnoses. Disease activity during the period of followup was measured by the Disease Activity Score. Outcome in terms of physical disability (Health Assessment Questionnaire) and radiological damage (Sharp's modified version) over 3 and 6 year periods was determined.
RESULTS: In the group of 186 patients, with mean disease duration of 4.3 years at January 1991, 50 patients (27%) reported at least one chronic coexisting disease. The most frequently reported coexisting diseases were of cardiovascular (29%), respiratory (18%), or dermatological (11%) origin. For the major part (66%) chronic coexisting diseases were already present before onset of RA. No statistically significant differences in use of disease modifying antirheumatic drugs or corticosteroids were observed between RA patients with and without chronic coexisting diseases. No statistically significant differences were found in disease activity or in outcome in terms of physical disability and radiological damage over 3 and 6 year periods between the 2 groups with RA.
CONCLUSION: The results showed that about 27% of patients with RA in this inception cohort had at least one chronic coexisting disease. Treatment, disease course, and outcome did not differ between patients with and without chronic coexisting diseases during the first years of the disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11469455

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

1.  Characteristics of patients with rheumatoid arthritis in France: a study of 1109 patients managed by hospital based rheumatologists.

Authors:  J Sany; P Bourgeois; A Saraux; S Durieux; A Lafuma; J P Daurès; F Guillemin; J Sibilia
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

2.  Comorbid conditions are associated with healthcare utilization, medical charges and mortality of patients with rheumatoid arthritis.

Authors:  Guang-Ming Han; Xiao-Feng Han
Journal:  Clin Rheumatol       Date:  2016-04-23       Impact factor: 2.980

3.  [Comorbidity in rheumatoid arthritis of early onset. Effects on outcome parameters].

Authors:  G Westhoff; C Weber; A Zink
Journal:  Z Rheumatol       Date:  2006-10       Impact factor: 1.372

4.  Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry.

Authors:  Sara Monti; Catherine Klersy; Roberto Gorla; Piercarlo Sarzi-Puttini; Fabiola Atzeni; Raffaele Pellerito; Enrico Fusaro; Giuseppe Paolazzi; Pier Andrea Rocchetta; Ennio Giulio Favalli; Antonio Marchesoni; Roberto Caporali
Journal:  Clin Rheumatol       Date:  2017-01-05       Impact factor: 2.980

5.  Older age at rheumatoid arthritis onset and comorbidities correlate with less Health Assessment Questionnaire-Disability Index and Clinical Disease Activity Index response to etanercept in the RADIUS 2 registry.

Authors:  William J Martin; Man Shim; Harold E Paulus; Sandeep Chaudhari; JingYuan Feng; David Elashoff; Theodore J Hahn; Veena K Ranganath
Journal:  J Clin Rheumatol       Date:  2014-09       Impact factor: 3.517

6.  Cutaneous abnormalities in rheumatoid arthritis compared with non-inflammatory rheumatic conditions.

Authors:  K M J Douglas; E Ladoyanni; G J Treharne; E D Hale; N Erb; G D Kitas
Journal:  Ann Rheum Dis       Date:  2006-02-13       Impact factor: 19.103

7.  Cardiovascular Comorbidities Relate More than Others with Disease Activity in Rheumatoid Arthritis.

Authors:  Gloria Crepaldi; Carlo Alberto Scirè; Greta Carrara; Garifallia Sakellariou; Roberto Caporali; Ihsane Hmamouchi; Maxime Dougados; Carlomaurizio Montecucco
Journal:  PLoS One       Date:  2016-01-12       Impact factor: 3.240

8.  Does non-adherence to DMARDs influence hospital-related healthcare costs for early arthritis in the first year of treatment?

Authors:  Annelieke Pasma; Charlotte Schenk; Reinier Timman; Adriaan van 't Spijker; Cathelijne Appels; Willemijn H van der Laan; Bart van den Bemt; Robert Goekoop; Johanna M W Hazes; Jan J V Busschbach
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

9.  Co-morbidity in patients with early rheumatoid arthritis - inflammation matters.

Authors:  Lena Innala; Clara Sjöberg; Bozena Möller; Lotta Ljung; Torgny Smedby; Anna Södergren; Staffan Magnusson; Solbritt Rantapää-Dahlqvist; Solveig Wållberg-Jonsson
Journal:  Arthritis Res Ther       Date:  2016-01-28       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.